Article
Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Oct 2003
Yamada Kaoru, Ramezani Ali, Hawley Robert G, Ebell Wolfram, Arwert Fre, Arnold Larry W, Walsh Christopher E
Abstract excerpt
Fanconi anemia (FA) is an autosomal recessive disease characterized by progressive bone marrow failure due to defective stem cell function. FA patients' cells are hypersensitive to DNA cross-linking agents such as mitomycin C (MMC), exposure to which results in cytogenetic aberrations and cell death. To date Moloney murine leukemia virus vectors have been used in clinical gene therapy. Recently, third-generation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
